Nanox shows end‑to‑end kit

Most medical imaging is still sold like a machine purchase: buy the scanner, then find separate software, separate readers, and separate follow-up. At the European Congress of Radiology in Vienna on March 4–8, 2026, Nanox showed the opposite package: one company pitching the scanner, the artificial intelligence tools, and the service layer together. (ecr2026.org, appliedradiology.com) The scanner at the center of the booth was Nanox.ARC, which is not a full computed tomography machine. It uses digital tomosynthesis, a method that takes multiple low-dose X-ray images from different angles and rebuilds them into slice-like views, like flipping a stack of thin pages instead of looking at one flat photo. (appliedradiology.com, radiologyinfo.org) That middle ground matters because plain X-rays are cheap but flatten everything into one image, while computed tomography gives far more detail but usually costs more, uses more radiation, and needs a bigger installation. Nanox says Nanox.ARC is meant to sit between those two options, with a smaller footprint and lower radiation dose than traditional computed tomography. (appliedradiology.com, kommunikasjon.ntb.no) Nanox used the Vienna show to put that hardware in front of European buyers live for the first time. The company said the system is both Food and Drug Administration cleared in the United States and Conformité Européenne marked in Europe, and it ran live booth demonstrations every 30 minutes in Hall X4. (kommunikasjon.ntb.no, nanox.vision) The software layer is where the pitch turns from “better X-ray” into “workflow product.” Nanox showed Food and Drug Administration cleared artificial intelligence tools that scan routine computed tomography images for coronary calcium, low bone density and vertebral fractures, and fatty liver signals, so one scan can flag problems that were not the original reason for the exam. (kommunikasjon.ntb.no, diagnosticimaging.com) Then comes the service layer. Nanox has been tying those artificial intelligence tools into a teleradiology and second-opinion platform, which means the company is not only selling image capture but also selling the path from scan to outside review to report support. (diagnosticimaging.com, nanox.vision) That is the real shift behind this booth: equipment makers are increasingly trying to sell an operating system for imaging, not just a box that makes pictures. If a clinic can get the machine, cloud upgrades, disease-detection software, and reading support in one contract, the buying decision starts to look more like subscribing to a platform than outfitting a radiology room piece by piece. (nanox.vision, (accessdata.fda.gov)) Nanox’s own language makes that strategy explicit. Its site describes “a seamless, end-to-end solution, from scan to diagnosis,” and the April 16, 2025 Food and Drug Administration clearance summary for Nanox.ARC X says image reconstruction and protocol services can be hosted locally or through Nanox.CLOUD, which turns updates and workflow services into part of the product itself. (nanox.vision, accessdata.fda.gov) The company also used ECR to show how that bundle can expand over time without swapping out the room. It highlighted a recently Food and Drug Administration cleared cloud image-enhancement feature called TAP2D and said new software capabilities can be added remotely after regulatory clearances. (kommunikasjon.ntb.no) So the Vienna exhibit was not just a scanner demo. It was a preview of where imaging sales are heading: fewer standalone machines, more bundled systems that try to own the hardware, the analysis, and the follow-through in one stack. (appliedradiology.com, nanox.vision)